These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 15393715)

  • 1. The use of fluorescein dyes in the diagnosis of malignancy with special reference to tumors of the central nervous system.
    HUBBARD TB; MOORE GE
    J Natl Cancer Inst; 1949 Oct; 10(2):303-14. PubMed ID: 15393715
    [No Abstract]   [Full Text] [Related]  

  • 2. Clinical and Experimental Studies of Fluorescein Dyes with Special Reference to their Use for the Diagnosis of Central Nervous System Tumors.
    Moore GE; Hunter SW; Hubbard TB
    Ann Surg; 1949 Oct; 130(4):637-42. PubMed ID: 17859457
    [No Abstract]   [Full Text] [Related]  

  • 3. The clinical use of radioactive di-iodo-fluorescein in the diagnosis and localization of tumors of the central nervous system.
    DAVIS L; MARTIN J; ASHKENAZY M; LeROY GV; FIELDS T
    Trans Am Neurol Assoc; 1950; 51():8-12. PubMed ID: 14788066
    [No Abstract]   [Full Text] [Related]  

  • 4. Clinical use of radioactive diiodofluorescein in diagnosis and localization of tumors of the central nervous system in 105 consecutive patients.
    DAVIS L; MARTIN J; ASHKENAZY M
    AMA Arch Neurol Psychiatry; 1951 Jan; 65(1):97-9. PubMed ID: 14782776
    [No Abstract]   [Full Text] [Related]  

  • 5. Radioactive diiodofluorescein in diagnosis and localization of central nervous system tumors.
    DAVIS L; MARTIN J; ASHKENAZY M; LeROY GV; FIELDS T
    J Am Med Assoc; 1950 Dec; 144(17):1424-32. PubMed ID: 14794359
    [No Abstract]   [Full Text] [Related]  

  • 6. Clinical and experimental studies of intracranial tumors with fluorescein dyes with an additional note concerning the possible use of K42 and iodine 131 tagged human albumin.
    MOORE GE; CAUDILL CM; MARVIN JF; AUST JB; CHOU SN; SMITH GA
    Am J Roentgenol Radium Ther; 1951 Jul; 66(1):1-8. PubMed ID: 14847039
    [No Abstract]   [Full Text] [Related]  

  • 7. [MAPPING OF THE PATHWAYS IN THE NERVOUS SYSTEM].
    BRODAL A
    Tidsskr Nor Laegeforen; 1965 Jan; 85():103-12. PubMed ID: 14299937
    [No Abstract]   [Full Text] [Related]  

  • 8. [Minimum concentrations of aniline affecting the central nervous system in rabbits].
    ZAKABUNINA MS
    Farmakol Toksikol; 1955; 18(3):41-5. PubMed ID: 13241562
    [No Abstract]   [Full Text] [Related]  

  • 9. [Determination of minimal dose of certain aniline derivatives acting upon the central nervous system in rabbits].
    ZAKABUNINA MS
    Farmakol Toksikol; 1955; 18(5):43-6. PubMed ID: 13294201
    [No Abstract]   [Full Text] [Related]  

  • 10. COMBINED STAINING OF CENTRAL NERVOUS SYSTEM TISSUE WITH LUXOL FAST BLUE AND BASIC FUCHSIN.
    SZABO I
    Acta Morphol Acad Sci Hung; 1965; 13():251-4. PubMed ID: 14329846
    [No Abstract]   [Full Text] [Related]  

  • 11. The use of the smear technique in the rapid histological diagnosis of tumors of the central nervous system; description of a new staining method.
    MORRIS AA
    J Neurosurg; 1947 Nov; 4(6):497-504. PubMed ID: 20267938
    [No Abstract]   [Full Text] [Related]  

  • 12. [Role of the nervous system in fluorescein permeability].
    LUGOSSY G
    Szemeszet; 1959 Sep; 96():108-20. PubMed ID: 14418796
    [No Abstract]   [Full Text] [Related]  

  • 13. The clinical use of radioactive di-iodo-fluorescein in the diagnosis and localization of organic lesions of the central nervous system.
    DAVIS L; MARTIN J; ASHKENAZY M; LeROY GV; FIELDS T
    Surg Forum; 1950; ():357-62. PubMed ID: 14828520
    [No Abstract]   [Full Text] [Related]  

  • 14. [ON THE SIGNIFICANCE OF INCLUSIONS STAINABLE BY ALDEHYDE-FUCHSIN IN NEURONS OF THE RAT CENTRAL NERVOUS SYSTEM].
    STUTINSKY F; PORTE A; TRANZER JP; TERMINN Y
    C R Seances Soc Biol Fil; 1963; 157():2294-6. PubMed ID: 14137456
    [No Abstract]   [Full Text] [Related]  

  • 15. Highlights on the differential diagnosis of cancer in the central nervous system.
    OLDBERG E
    Ill Cancer Bull; 1947 Aug; 2(7):1. PubMed ID: 20255234
    [No Abstract]   [Full Text] [Related]  

  • 16. Transport and effects of cationic dyes and tetrazolium salts in the central nervous system.
    Koenig H
    Prog Brain Res; 1968; 29():87-123. PubMed ID: 5735125
    [No Abstract]   [Full Text] [Related]  

  • 17. [Tumors due to abnormality of the central nervous system with special reference to dermoid cysts].
    LORENZO A; WEBER E
    Z Kinderheilkd; 1960; 83():386-97. PubMed ID: 14418307
    [No Abstract]   [Full Text] [Related]  

  • 18. [THE AFFERENT INNERVATION OF TUMORS].
    SCORODUMOVA IV
    Acta Unio Int Contra Cancrum; 1964; 20():1626-8. PubMed ID: 14242979
    [No Abstract]   [Full Text] [Related]  

  • 19. THE QUESTION OF THE INTERNAL LIMITING MEMBRANE OF DEVELOPING CNS, ITS STRUCTURE AND MEANING.
    KLIKA E; JELINEK R
    Z Mikrosk Anat Forsch; 1963; 70():282-97. PubMed ID: 14124513
    [No Abstract]   [Full Text] [Related]  

  • 20. Acute toxicity of fluorescein to turbot (Scophthalmus maximus).
    Pouliquen H; Algoet M; Buchet V; Le Bris H
    Vet Hum Toxicol; 1995 Dec; 37(6):527-9. PubMed ID: 8588287
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.